e-ESO Podcasts
Podcast tekijän mukaan ESO - European School of Oncology
143 Jaksot
-
Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
Julkaistiin: 2.2.2023 -
Basics of prostate cancer pathology
Julkaistiin: 26.1.2023 -
Oligometastaic breast cancer
Julkaistiin: 19.1.2023 -
Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias
Julkaistiin: 12.1.2023 -
Summary/Review - Reporting Guidelines - CHEERS
Julkaistiin: 6.12.2022 -
Role of immunotherapy in head and neck cancer
Julkaistiin: 1.12.2022 -
AYAs with cancer: the right to be forgotten
Julkaistiin: 24.11.2022 -
Summary/Review - Reporting Guidelines - SQUIRE
Julkaistiin: 17.11.2022 -
Male breast cancer
Julkaistiin: 10.11.2022 -
Summary/Review - Reporting Guidelines - SRQR
Julkaistiin: 3.11.2022 -
Summary/Review - Reporting Guidelines - AGREE
Julkaistiin: 27.10.2022 -
Breast Cancer: Frequently Asked Questions and Answers
Julkaistiin: 20.10.2022 -
The role of Medical Physicist in Oncology
Julkaistiin: 13.10.2022 -
How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively?
Julkaistiin: 6.10.2022 -
Parp inhibitors in ovarian cancer
Julkaistiin: 29.9.2022 -
Primary endocrine resistant in recurrent locoregional only Breast cancer (role of endocrine therapy)
Julkaistiin: 22.9.2022 -
Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?
Julkaistiin: 15.9.2022 -
The use of Lutetium PSMA as treatment in mCRPC – in what sequence and how to best select patients
Julkaistiin: 8.9.2022 -
Use of Medical Cannabis in Oncology. Knowledges and attitudes among oncologist and patient.
Julkaistiin: 1.9.2022 -
Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
Julkaistiin: 27.7.2022
e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net